Literature DB >> 15194637

Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type.

P Lehours1, S Dupouy, B Bergey, A Ruskoné-Foumestraux, J C Delchier, R Rad, F Richy, J Tankovic, F Zerbib, F Mégraud, A Ménard.   

Abstract

BACKGROUND AND AIMS: Gastric extranodal marginal zone B cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type (MZBL) is a rare complication of Helicobacter pylori infection. Currently, no bacterial factor has been associated with the development of this disease. Our aim was to identify genes associated with lymphoma development.
METHODS: We used subtractive hybridisation as a tool for comparative genomics between H pylori strains isolated from a patient with gastric MZBL and from a patient with gastritis only.
RESULTS: When gastric MZBL strains were compared with gastritis strains, two open reading frames (ORFs) were significantly associated with gastric MZBL: JHP950 (74.4% v 48.7%, respectively; p = 0.023) and JHP1462 (25.6% v 2.6%, respectively; p = 0.004). The prevalence of JHP950 was 48.8% (p = 0.024) in duodenal ulcer strains and 39.3% (p = 0.006) in gastric adenocarcinoma strains, which makes this ORF a specific marker for gastric MZBL strains. In contrast, the prevalence of JHP1462 was 16% (p = 0.545) and 35.7% (p = 0.429) in duodenal ulcer and adenocarcinoma strains, respectively. These ORFs were present in reference strain J99 but not in reference strain 26695. JHP950 is located in the plasticity zone whereas the other, JHP1462, is located outside. Both encode for H pylori putative proteins with unknown functions.
CONCLUSION: Despite its low prevalence, the ORF JHP1462 can be considered a candidate marker for H pylori strains involved in severe gastroduodenal diseases. In contrast, the ORF JHP950 has a high prevalence, and is the first candidate marker for strains giving rise to an increased risk of gastric MZBL strains. Further confirmation in other studies is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194637      PMCID: PMC1774103          DOI: 10.1136/gut.2003.028811

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

Authors:  S Censini; C Lange; Z Xiang; J E Crabtree; P Ghiara; M Borodovsky; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

2.  H pylori and gastric cancer.

Authors:  D Forman; P Webb; J Parsonnet
Journal:  Lancet       Date:  1994-01-22       Impact factor: 79.321

3.  Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks.

Authors:  P Correa; J Fox; E Fontham; B Ruiz; Y P Lin; D Zavala; N Taylor; D Mackinley; E de Lima; H Portilla
Journal:  Cancer       Date:  1990-12-15       Impact factor: 6.860

4.  Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.

Authors:  H Liu; A Ruskon-Fourmestraux; A Lavergne-Slove; H Ye; T Molina; Y Bouhnik; R A Hamoudi; T C Diss; A Dogan; F Megraud; J C Rambaud; M Q Du; P G Isaacson
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

5.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Authors:  A C Wotherspoon; C Doglioni; T C Diss; L Pan; A Moschini; M de Boni; P G Isaacson
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

6.  The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori.

Authors:  T Hussell; P G Isaacson; J E Crabtree; J Spencer
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

7.  Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue.

Authors:  T Hussell; P G Isaacson; J E Crabtree; J Spencer
Journal:  J Pathol       Date:  1996-02       Impact factor: 7.996

8.  Helicobacter pylori infection and gastric lymphoma.

Authors:  J Parsonnet; S Hansen; L Rodriguez; A B Gelb; R A Warnke; E Jellum; N Orentreich; J H Vogelman; G D Friedman
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

9.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Schistosomes, liver flukes and Helicobacter pylori.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1994
View more
  18 in total

1.  Identification of markers for Helicobacter pylori strains isolated from children with peptic ulcer disease by suppressive subtractive hybridization.

Authors:  Mónica Oleastro; Lurdes Monteiro; Philippe Lehours; Francis Mégraud; Armelle Ménard
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases.

Authors:  Mitsushige Sugimoto; Masahide Watada; Sung Woo Jung; David Y Graham; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

3.  Complexomics study of two Helicobacter pylori strains of two pathological origins: potential targets for vaccine development and new insight in bacteria metabolism.

Authors:  Cédric Bernarde; Philippe Lehours; Jean-Paul Lasserre; Michel Castroviejo; Marc Bonneu; Francis Mégraud; Armelle Ménard
Journal:  Mol Cell Proteomics       Date:  2010-07-07       Impact factor: 5.911

4.  Differences in genome content among Helicobacter pylori isolates from patients with gastritis, duodenal ulcer, or gastric cancer reveal novel disease-associated genes.

Authors:  Carolina Romo-González; Nina R Salama; Juan Burgeño-Ferreira; Veronica Ponce-Castañeda; Eduardo Lazcano-Ponce; Margarita Camorlinga-Ponce; Javier Torres
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

Review 5.  Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma.

Authors:  Mathijs P Bergman; Mario M D'Elios
Journal:  J Biomed Biotechnol       Date:  2010-06-22

Review 6.  Comparative genomics of Helicobacter pylori.

Authors:  Quan-Jiang Dong; Qing Wang; Ying-Nin Xin; Ni Li; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

Review 7.  Roles of the plasticity regions of Helicobacter pylori in gastroduodenal pathogenesis.

Authors:  Yoshio Yamaoka
Journal:  J Med Microbiol       Date:  2008-05       Impact factor: 2.472

8.  From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma.

Authors:  Jean-Michel Thiberge; Caroline Boursaux-Eude; Philippe Lehours; Marie-Agnès Dillies; Sophie Creno; Jean-Yves Coppée; Zoé Rouy; Aurélie Lajus; Laurence Ma; Christophe Burucoa; Anne Ruskoné-Foumestraux; Anne Courillon-Mallet; Hilde De Reuse; Ivo Gomperts Boneca; Dominique Lamarque; Francis Mégraud; Jean-Charles Delchier; Claudine Médigue; Christiane Bouchier; Agnès Labigne; Josette Raymond
Journal:  BMC Genomics       Date:  2010-06-10       Impact factor: 3.969

9.  Gastric lymphoma: association with Helicobacter pylori outer membrane protein Q (HopQ) and cytotoxic-pathogenicity activity island (CPAI) genes.

Authors:  J Yakoob; Z Abbas; Z Ahmad; K Tariq; S Awan; K Mustafa; R Khan
Journal:  Epidemiol Infect       Date:  2017-11-16       Impact factor: 4.434

10.  Is there a link between the lipopolysaccharide of Helicobacter pylori gastric MALT lymphoma associated strains and lymphoma pathogenesis?

Authors:  Philippe Lehours; Zongli Zheng; Anna Skoglund; Francis Mégraud; Lars Engstrand
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.